Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | NOTE 1 1 . STOCK-BASED COMPENSATION Except for the stock compensation expense section, all amounts consist of both continuing and discontinued operations. Employee Stock Participation Plan (“ESPP”) Our ESPP permits employees to purchase common stock through payroll deductions at a purchase price that is equal to 95% three The following table summarizes our ESPP transactions during the fiscal periods presented (in thousands, except per share amounts): As of Nine Months Ended January 1, 2017 January 1, 2017 Weighted Shares of Shares of Average Common Stock Common Stock Price per Share Authorized to issue 4,500 Reserved for future issuance 1,298 Issued 19 $ 7.54 Equity Incentive Plans At the annual meeting of stockholders on September 18, 2014 2014 (“2014 2014 Prior to the Annual Meeting, we maintained the Exar Corporation 2006 “2006 2006 2006 June 30, 2014, 6,555,492 2006 2006 669,008 2006 2014 2006 2006 The maximum number of shares of our common stock that may 2014 (1) 5,170,000 (2) 2006 2006 and outstanding as of the date of the Annual Meeting which expire, or for any reason are cancelled or terminated, after the date of the Annual Meeting without being exercised, plus (3) 2006 2006 2014 two January 1, 2017, approximately 3.3 2014 Stock Option Activities Our stock option transactions during the nine January 1, 2017 Weighted Average In-the-money Weighted Remaining Aggregate Options Outstanding Average Contractual Intrinsic Vested and Options / Exercise Term Value Exercisable Quantity Price per Share (in years) (in thousands) (in thousands) Balance at March 27, 2016 7,722,383 $ 7.96 4.40 $ 87 48 Granted 1,466,800 7.30 Exercised (2,045,504 ) 6.97 Cancelled (614,454 ) 9.84 Forfeited (1,055,074 ) 7.53 Balance at January 1, 2017 5,474,151 8.02 4.66 16,195 4,787 Vested and expected to vest, January 1, 2017 4,909,103 8.12 4.50 14,140 Vested and exercisable, January 1, 2017 2,491,344 $ 8.85 3.19 $ 5,620 The aggregate intrinsic values in the table above represent the total pre-tax intrinsic value, which is based on the closing price of our common stock of $10.78 $5.26 January 1, 2017 March 27, 2016, These are the values which would have been received by option holders if all option holders exercised their options on that date. In January 2012, 480,000 four 2013 2016 January 2014, 140,000 2017 October 2015, $34,000 2016 On July 1, 2016 280,000 120,000 four four January 1, 2017, $0.2 Options exercised for the periods indicated below were as follows (in thousands): Three Months Ended Nine Months Ended January 1, December 27, January 1, December 27, 2017 2015 2017 2015 Intrinsic value of options exercised $ 1,367 $ 39 $ 4,085 $ 637 RSU Activities Our RSU transactions during the nine January 1, 2017 Weighted Average Weighted Remaining Aggregate Average Contractual Intrinsic Grant-Date Term Value Shares Fair Value (in years) (in thousands) Unvested at March 27, 2016 590,833 $ 9.39 1.45 $ 3,108 Granted 622,039 8.63 Issued and released (209,236 ) 8.94 Forfeited (215,029 ) 9.68 Unvested at January 1, 2017 788,607 $ 8.83 1.81 $ 8,501 Vested and expected to vest, January 1, 2017 608,111 1.62 6,555 The aggregate intrinsic value of RSUs represents the closing price per share of our stock at the end of the periods presented, multiplied by the number of unvested RSUs or the number of vested and expected to vest RSUs, as applicable, at the end of each period. For RSUs, stock-based compensation expense was calculated based on our stock price on the date of grant, multiplied by the number of RSUs granted. The grant date fair value of RSUs less estimated forfeitures was recognized on a straight-line basis, over the vesting period. In March 2012, 300,000 to our then CEO. The PRSUs were scheduled to vest in three 2013 2015 three October, 2015, $41,000 2016, In July 2013, five July 2015 three nine January 1, 2017. $0.2 three nine December 27, 2015.The July 2015, 2016 three five $75,000 may two $1.2 January 1, 2017, In October 2013, 70,000 first 50% three 2015 three second 50% three 2016 three $5,000 $42,000 three nine January 1, 2017, $18,000 $96,000 three nine December 27, 2015, 2015. In August December 2014, 88,448 three June 2016 one $311,000 three July 3, 2016. $0.2 $0.7 three nine January 1, 2017, In July 2016, 60,000 30,000 three one third 12 two Expected term of grants (years) 3 Risk-free interest rate 0.76 % Expected volatility 50 % For the three nine January 1, 2017, $56,000 $80,000 In July 2016, 2017 (“2017 2017. $2.2 nine January 1, 2017. Stock-Based Compensation Expense The following table summarizes stock-based compensation expense related to stock options and RSUs for continuing operations during the fiscal periods presented (in thousands): Three Months Ended Nine Months Ended January 1, December 27, January 1, December 27, 2017 2015 2017 2015 Cost of sales $ 474 $ 98 $ 889 $ 257 Research and development 926 117 1,696 509 Selling, general and administrative 2,234 596 4,546 3,044 Total stock-based compensation expense $ 3,634 $ 811 $ 7,131 $ 3,810 The amount of stock-based compensation cost capitalized in inventory was immaterial for all periods presented. Unrecognized Stock-Based Compensation Expense The following table summarizes unrecognized stock-based compensation expense related to stock options and RSUs, net of reversals, as of January 1, 2017: January 1, 2017 Weighted Average Remaining Amount Recognition (in thousands) Period (in years) Options $ 4,887 2.59 RSUs 4,557 2.58 PRSUs 630 1.69 Total unrecognized stock-based compensation expense $ 10,074 |